Results also add support that the disease is more aggressive in youth NIH/NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the...
Tag: <span>insulin</span>
Post
A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes — and no one is certain why
By ELIE DOLGINMAY 29, 2019 The first two rounds of treatment went off without a hitch. But last November, after receiving a third dose of potent immunotherapy for his skin cancer, Rich Lenihan started to feel tired and weak. He was urinating constantly, and no amount of water could abate his thirst. A blood test...
Post
Newly discovered immune cell linked to type 1 diabetes
Rogue defender’ mistakenly spurs attacks on insulin-producing cells in pancreas JOHNS HOPKINS MEDICINE In a discovery that might be likened to finding medicine’s version of the Loch Ness monster, a research team from Johns Hopkins Medicine, IBM Research and four collaborating institutions is the first to document the existence of long-doubted “X cell,” a “rogue hybrid” immune system cell that...
Post
Can diabetes influence cancer’s spread?
Published Today By Maria Cohut Fact checked by Carolyn Robertson Some researchers argue that there may be a direct link between having diabetes and exposure to an increased risk of metastasis in cancer. New research validates this idea, explaining how diabetes can elevate this risk. Hundreds of millions of people across the globe live with...
Post
Frailty may up fracture risk in patients with type 2 diabetes
(HealthDay)—Patients with type 2 diabetes are frailer than participants without diabetes, and frailty increases the risk for fragility fractures, according to a study published in the April issue of Diabetes Care. Guowei Li, from Guangdong Second Provincial General Hospital in Guangzhou, China, and colleagues assessed whether frailty was associated with fracture risk and whether frailty could modify the propensity of type 2 diabetes toward an increased risk for fractures...
Post
How much difference will Eli Lilly’s half-price insulin make?
When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid another $280.51. “It eats at me to know that taxpayer money is being wasted,” said Gilmer, who has Medicare and was diagnosed with Type 1 diabetes while a sophomore at the University of Colorado in 2002. The diagnosis...
Post
Lilly will sell a version of its popular insulin at half the price, but will this appease critics?
By ED SILVERMAN @Pharmalot MARCH 4, 2019 As drug makers come under increasing pressure to lower prices, Eli Lilly (LLY) is trying to thread a needle by introducing a new version of insulin at half the list price. Specifically, the product is a so-called authorized generic version of the Humalog insulin, which means the medicine is identical to the brand-name...
Post
‘Everyone is at fault’: With insulin prices skyrocketing, there’s plenty of blame to go around
WASHINGTON — Fifteen years ago, a patient with diabetes might have paid $175.57 for a 20-milliliter vial of the long-acting insulin Humulin R U-500. Today, he’d shell out $1,487 for the same tiny vial, according to wholesale acquisition cost data from Elsevier’s Gold Standard Drug Database. It’s easy to cast blame on the drug makers:...
Post
BD Unveils Nano Pen Needle for Accurate Subcutaneous Insulin Injections
BD is releasing its new Nano pen needle designed for achieving consistent depth during subcutaneous injections, particularly for diabetic patients on insulin. Intramuscular injections can occur when a patient applies too much force to many of the existing injection devices. The new BD Nano compensates for this by spreading the load across the injection site...
Post
Investigators study effect of switching insulin medications
Boston, MA — In the United States, the drug price for insulin has skyrocketed over the last two decades. While the price has increased for all forms of insulin, newer, “analogue” insulin medications such as glargine and lispro have become especially expensive. This is particularly true for patients with insufficient drug coverage or for Medicare...